Andrew Von Eschenbach

Dr. von Eschenbach serves on the Board of Directors of the Reagan-Udall Foundation for the Food and Drug Administration. He is currently President of Samaritan Health Initiatives, a private consulting firm that focuses on improving the ecosystem for the discovery, development, and delivery of innovative 21st century solutions to eliminate disease and restore health, and an Adjunct Professor at the University of Texas UT MD Anderson Cancer Center. In addition, Dr. von Eschenbach is a Senior Fellow and Board member of various research institutions, pharmaceutical and healthcare companies. From 2006 to 2009, Dr. von Eschenbach served as Commissioner of the U.S. Drug and Food Administration, after being appointed Acting Commissioner in 2005. Prior to that, he served as Director of the National Cancer Institute from 2002 to 2006, after spending 26 years at the University of Texas M.D. Anderson Cancer Center, including as Director, Genitourinary Cancer Center.

Dr. von Eschenbach received a B.S. in biology from St. Joseph's University and a MD from Georgetown University School of Medicine.